Market Overview:
The global prescription dermatological drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of skin diseases, rising awareness about available treatment options, and growing demand for better-quality products. The global prescription dermatological drugs market can be segmented on the basis of type into anti-acne drugs, anti-aging drugs, dermatitis drugs, hair loss drugs, psoriasis drugs, skin cancer drugs, melasma Drugs and seborrhea Drugs. On the basis of application ,the market can be divided into hospital pharmacies , retail pharmacies and online pharmacies .Regionally ,the global prescription dermatological drug market is segmented into North America Latin America Europe Asia Pacific and Middle East & Africa . Some of the key players operating in this market are Johnson & Johnson (U.S.), GlaxoSmithKline plc (U.K.), L’Oréal S.A.(France), Bayer AG (Germany), Pfizer Inc.(U.S.), Novartis AG(Switzerland)and Allergan plc(Ireland).
Product Definition:
A prescription dermatological drug is a medication that is dispensed only with a written prescription from a healthcare provider. These drugs are used to treat various skin conditions, including acne, psoriasis, and rosacea. Prescription dermatological drugs are important because they can help to improve the appearance and health of the skin.
Anti-acne Drugs:
Anti-acne drugs are the medicines used to treat acne. The global anti-acne drugs market is expected to grow at a significant rate during the forecast period. Factors such as growing awareness about acne and its treatment, increasing disposable income, changing lifestyle of people and rapid urbanization in emerging economies are driving the growth of this market globally.
Anti-aging Drugs:
Anti-aging drugs are used to slow down or halt the signs of aging. These include retinoids, hyaluronic acid, and vitamins. The most commonly prescribed anti-aging drugs in dermatology are sunscreen products such as creams, lotions & sunscreens; alpha-hydroxy acids (AHA); and hydroxy acids (BHA).
Application Insights:
The general dermatology segment dominated the global prescription dermatological drugs market in 2017. This is owing to a large patient base and high prevalence of skin diseases such as acne, eczema, psoriasis and skin cancer. Furthermore, an increase in the number of hospital-based clinics has also boosted demand for various drugs used for treating these conditions.
On the other hand, anti-acne drugs are widely used for treating different types of acne vulgaris including blackheads and pimples. The increasing cases of acne have led to increased utilization of anti-acne medications that are commonly available as creams or gels that can be applied directly onto the affected area once every two days till completion of a prescribed course.
Regional Analysis:
North America dominated the global prescription dermatological drugs market in 2017. This can be attributed to rising awareness about early diagnosis and treatment of skin diseases, increasing adoption of new technologies such as digital dermatology, and presence of well-established healthcare facilities in this region. Moreover, high prevalence of skin cancer and other disorders like acne vulgaris is also expected to boost the demand for these products over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rise in disposable income coupled with growing medical tourism industry mainly due to availability of effective treatments at affordable costs along with advanced infrastructure & technology used for diagnostics & treatment purposes.
Growth Factors:
- Increasing prevalence of skin diseases: The global prevalence of skin diseases is increasing every year. This is mainly due to the changing lifestyles and environmental conditions. This, in turn, is driving the demand for prescription dermatological drugs.
- Growing awareness about skin health: There has been a growing awareness among people about the importance of taking care of their skin health. This is leading to an increase in the demand for prescription dermatological drugs.
- Rising incidence of acne: Acne is one of the most common skin problems faced by people across all age groups. The rising incidence of acne is leading to an increase in demand for prescription dermatological drugs that can treat this condition effectively.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prescription Dermatological Drugs Market Research Report
By Type
Anti-acne Drugs, Anti-aging Drugs, Dermatitis Drugs, Hair Loss Drugs, Psoriasis Drugs, Skin Cancer Drugs, Melasma Drugs, Seborrhea Drugs
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Johnson & Johnson, Merck, LEO Pharma, Mylan Pharmaceuticals, Pfizer, Roche, Allergan, Bausch Health, PharmaDerm Pharmaceuticals, Allergan Inamed Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Prescription Dermatological Drugs Market Report Segments:
The global Prescription Dermatological Drugs market is segmented on the basis of:
Types
Anti-acne Drugs, Anti-aging Drugs, Dermatitis Drugs, Hair Loss Drugs, Psoriasis Drugs, Skin Cancer Drugs, Melasma Drugs, Seborrhea Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Merck
- LEO Pharma
- Mylan Pharmaceuticals
- Pfizer
- Roche
- Allergan
- Bausch Health
- PharmaDerm Pharmaceuticals
- Allergan Inamed Corporation
Highlights of The Prescription Dermatological Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-acne Drugs
- Anti-aging Drugs
- Dermatitis Drugs
- Hair Loss Drugs
- Psoriasis Drugs
- Skin Cancer Drugs
- Melasma Drugs
- Seborrhea Drugs
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prescription Dermatological Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prescription dermatological drugs are medications used to treat skin conditions. They are often prescribed by a doctor after a diagnosis has been made.
Some of the key players operating in the prescription dermatological drugs market are Johnson & Johnson, Merck, LEO Pharma, Mylan Pharmaceuticals, Pfizer, Roche, Allergan, Bausch Health, PharmaDerm Pharmaceuticals, Allergan Inamed Corporation.
The prescription dermatological drugs market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prescription Dermatological Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prescription Dermatological Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prescription Dermatological Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prescription Dermatological Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prescription Dermatological Drugs Market Size & Forecast, 2018-2028
4.5.1 Prescription Dermatological Drugs Market Size and Y-o-Y Growth
4.5.2 Prescription Dermatological Drugs Market Absolute $ Opportunity
Chapter 5 Global Prescription Dermatological Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Prescription Dermatological Drugs Market Size Forecast by Type
5.2.1 Anti-acne Drugs
5.2.2 Anti-aging Drugs
5.2.3 Dermatitis Drugs
5.2.4 Hair Loss Drugs
5.2.5 Psoriasis Drugs
5.2.6 Skin Cancer Drugs
5.2.7 Melasma Drugs
5.2.8 Seborrhea Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Prescription Dermatological Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Prescription Dermatological Drugs Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prescription Dermatological Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prescription Dermatological Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Prescription Dermatological Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Prescription Dermatological Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Prescription Dermatological Drugs Market Size Forecast by Type
9.6.1 Anti-acne Drugs
9.6.2 Anti-aging Drugs
9.6.3 Dermatitis Drugs
9.6.4 Hair Loss Drugs
9.6.5 Psoriasis Drugs
9.6.6 Skin Cancer Drugs
9.6.7 Melasma Drugs
9.6.8 Seborrhea Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Prescription Dermatological Drugs Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Prescription Dermatological Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Prescription Dermatological Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Prescription Dermatological Drugs Market Size Forecast by Type
10.6.1 Anti-acne Drugs
10.6.2 Anti-aging Drugs
10.6.3 Dermatitis Drugs
10.6.4 Hair Loss Drugs
10.6.5 Psoriasis Drugs
10.6.6 Skin Cancer Drugs
10.6.7 Melasma Drugs
10.6.8 Seborrhea Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Prescription Dermatological Drugs Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Prescription Dermatological Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Prescription Dermatological Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Prescription Dermatological Drugs Market Size Forecast by Type
11.6.1 Anti-acne Drugs
11.6.2 Anti-aging Drugs
11.6.3 Dermatitis Drugs
11.6.4 Hair Loss Drugs
11.6.5 Psoriasis Drugs
11.6.6 Skin Cancer Drugs
11.6.7 Melasma Drugs
11.6.8 Seborrhea Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Prescription Dermatological Drugs Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Prescription Dermatological Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Prescription Dermatological Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Prescription Dermatological Drugs Market Size Forecast by Type
12.6.1 Anti-acne Drugs
12.6.2 Anti-aging Drugs
12.6.3 Dermatitis Drugs
12.6.4 Hair Loss Drugs
12.6.5 Psoriasis Drugs
12.6.6 Skin Cancer Drugs
12.6.7 Melasma Drugs
12.6.8 Seborrhea Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Prescription Dermatological Drugs Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Prescription Dermatological Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Prescription Dermatological Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Prescription Dermatological Drugs Market Size Forecast by Type
13.6.1 Anti-acne Drugs
13.6.2 Anti-aging Drugs
13.6.3 Dermatitis Drugs
13.6.4 Hair Loss Drugs
13.6.5 Psoriasis Drugs
13.6.6 Skin Cancer Drugs
13.6.7 Melasma Drugs
13.6.8 Seborrhea Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Prescription Dermatological Drugs Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prescription Dermatological Drugs Market: Competitive Dashboard
14.2 Global Prescription Dermatological Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Merck
14.3.3 LEO Pharma
14.3.4 Mylan Pharmaceuticals
14.3.5 Pfizer
14.3.6 Roche
14.3.7 Allergan
14.3.8 Bausch Health
14.3.9 PharmaDerm Pharmaceuticals
14.3.10 Allergan Inamed Corporation
